首頁 > 市場調查報告書 > 食物/飲料

市場調查報告書

商品編碼

1907939

基因改造動物市場按動物類型、技術、應用、疾病領域、最終用戶和地區分類

Transgenic Animal Market, By Animal Type, By Technology, By Application, By Disease Area, By End User, By Geography

出版日期: 2025年12月17日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

基因改造動物市場預計到 2025 年價值 39.6 億美元，預計到 2032 年將達到 79.2 億美元，2025 年至 2032 年的複合年成長率為 10.4%。

分析範圍		分析詳情
基準年	2024	市場規模（2025 年）	39.6億美元
效能數據	2020-2024	預測期	2025-2032
預測期（2025-2032 年）複合年成長率	10.40%	預計金額（2032 年）	79.2億美元

全球基因改造動物（基因改造動物）市場是生物技術和製藥行業的創新領域，涉及用於科學研究、藥物開發和治療應用的基因工程動物。基因改造動物透過基因工程技術製造，攜帶外源基因或經過改造的內源基因，使研究人員能夠研究人類疾病、測試潛在治療方法並開發新的治療方法。這些動物是理解複雜生物過程、遺傳疾病和疾病機制的重要活體模型，而這些過程、疾病和機制在傳統的實驗室環境中是無法重現的。

這個市場主要包括基因轉殖小鼠、大鼠、兔子、豬和其他專為生物醫學研究、藥物測試和學術研究而專門設計的實驗動物。由於對個人化醫療的需求不斷成長、遺傳疾病的盛行率上升以及生物技術研究投入的增加，基因改造動物市場正經歷顯著成長。該產業在加速藥物研發進程、縮短新療法上市時間以及透過更精準的臨床前測試模型提高臨床試驗成功率方面發揮著至關重要的作用。

市場動態

全球基因改造動物市場受多種強勁因素驅動，持續推動其在製藥和生物技術領域的擴張。關鍵成長要素包括對個人化醫療和標靶治療日益成長的需求，這需要先進的動物模型來了解個別基因變異和治療反應。遺傳性疾病、癌症、糖尿病和神經系統疾病的日益普遍，促使人們需要精準的疾病模型，而基因改造動物恰好能夠提供這種模型。生物技術研發投入的不斷增加，以及政府對基因組研究的資助，為市場成長奠定了堅實的基礎。

基因改造動物在藥物發現和開發過程中的廣泛應用顯著縮短了新藥上市的時間並降低了成本，使其成為製藥公司不可或缺的工具。然而，基因改造動物的應用仍存在許多局限性，包括嚴格的動物實驗監管、動物基因改造的倫理問題以及建構和維護基因改造動物族群的高成本。複雜的繁殖程序、特殊的飼養條件以及對專業技術人員的需求也為操作帶來了挑戰。

此外，諸如晶片器官技術和電腦建模等替代檢測方法的出現也構成了潛在的競爭威脅。儘管存在這些挑戰，但仍存在巨大的機遇，包括生物技術研究快速發展的新興市場、用於培育抗病牲畜的不斷擴大的農業應用，以及基因治療和再生醫學研究等新興治療領域對基因改造動物日益成長的需求。

本報告的主要特點

本報告對全球基因改造動物市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和複合年成長率。
它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
全球基因改造動物市場的主要企業將根據以下參數進行分析，例如公司概況、產品系列、主要亮點、財務績效和策略。
本報告提供的見解將使負責人和公司經營團隊能夠就未來的產品發布、產品更新、市場擴張和行銷策略做出明智的決策。
《全球基因改造動物市場》報告面向該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過各種用於分析全球基因改造動物市場的策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Charles River Laboratories
Taconic Biosciences
genOway
Cyagen Biosciences
Biocytogen
Transgenic Inc
Ozgene
PolyGene
Hera BioLabs
Ingenious Targeting Laboratory
Applied StemCell
GemPharmatech
Harbour BioMed
Crown Bioscience
Pharmaron

第11章分析師建議

機會
分析師觀點
Coherent Opportunity Map (COM)

第12章參考文獻與分析方法

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI9092

Transgenic Animal Market is estimated to be valued at USD 3.96 Bn in 2025 and is expected to reach USD 7.92 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.96 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.40%	2032 Value Projection:	USD 7.92 Bn

The global transgenic animal market represents a revolutionary segment within biotechnology and pharmaceutical industries, encompassing genetically modified animals engineered for scientific research, drug development, and therapeutic applications. Transgenic animals, created through genetic engineering techniques, carry foreign genes or modified endogenous genes that enable researchers to study human diseases, test potential treatments, and develop novel therapeutic approaches. These animals serve as crucial living models for understanding complex biological processes, genetic disorders, and disease mechanisms that would be impossible to replicate in traditional laboratory settings.

The market primarily includes transgenic mice, rats, rabbits, pigs, and other laboratory animals specifically designed for biomedical research, pharmaceutical testing, and academic studies. With increasing demand for personalized medicine, growing prevalence of genetic disorders, and rising investments in biotechnology research, the transgenic animal market has experienced significant growth. The industry plays a pivotal role in accelerating drug discovery processes, reducing time-to-market for new therapeutics, and enhancing the success rates of clinical trials through more accurate pre-clinical testing models.

Market Dynamics

The global transgenic animal market is driven by several compelling factors that continue to propel its expansion across pharmaceutical and biotechnology sectors. Primary growth drivers include the escalating demand for personalized medicine and targeted therapies, which require sophisticated animal models to understand individual genetic variations and treatment responses. The increasing prevalence of genetic disorders, cancer, diabetes, and neurological diseases has intensified the need for accurate disease models that transgenic animals uniquely provide. Rising investments in biotechnology research and development, coupled with government funding for genomic studies, have created a robust foundation for market growth.

The growing adoption of transgenic animals in drug discovery and development processes significantly reduces the time and cost associated with bringing new medications to market, making them indispensable tools for pharmaceutical companies. However, the market faces notable restraints including stringent regulatory frameworks governing animal research, ethical concerns surrounding genetic modification of animals, and high costs associated with developing and maintaining transgenic animal colonies. Complex breeding procedures, specialized housing requirements, and skilled personnel needs contribute to operational challenges.

Additionally, the emergence of alternative testing methods such as organ-on-chip technologies and computer modeling presents potential competitive threats. Despite these challenges, substantial opportunities exist in emerging markets where biotechnology research is expanding rapidly, increasing applications in agriculture for developing disease-resistant livestock, and growing demand for transgenic animals in emerging therapeutic areas including gene therapy and regenerative medicine research.

Key Features of the Study

This report provides in-depth analysis of the global transgenic animal market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global transgenic animal market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Charles River Laboratories, Taconic Biosciences, genOway, Cyagen Biosciences, Biocytogen, Transgenic Inc, Ozgene, PolyGene, Hera BioLabs, Ingenious Targeting Laboratory, Applied StemCell, GemPharmatech, Harbour BioMed, Crown Bioscience, and Pharmaron
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global transgenic animal market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transgenic animal market

Market Segmentation

Animal Type Insights (Revenue, USD Bn, 2020 - 2032)
- Mice
- Rats
- Zebrafish
- Pigs
- Cattle
- Sheep
- Goats
- Chickens
- Others (Non-human primates rabbits)
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Microinjection
- Embryonic Stem Cell (ESC) Injection
- Nuclear Transfer (Cloning)
- CRISPR/Cas9 and Other Gene Editing Technologies
- Viral Vector-mediated Transgenesis
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Biomedical Research
- Drug Discovery and Development
- Toxicology and Safety Testing
- Disease Modeling
- Regenerative Medicine
- Xenotransplantation
- Biopharmaceutical Production
- Agricultural Trait Enhancement
Disease Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurological Disorders
- Cardiovascular Diseases
- Metabolic Disorders
- Immunological and Autoimmune Diseases
- Genetic and Rare Diseases
- Infectious Diseases
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Academic and Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Agricultural Research Organizations
- Government and Regulatory Laboratories
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Charles River Laboratories
- Taconic Biosciences
- genOway
- Cyagen Biosciences
- Biocytogen
- Transgenic Inc
- Ozgene
- PolyGene
- Hera BioLabs
- Ingenious Targeting Laboratory
- Applied StemCell
- GemPharmatech
- Harbour BioMed
- Crown Bioscience
- Pharmaron

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Transgenic Animal Market, By Animal Type
- Global Transgenic Animal Market, By Technology
- Global Transgenic Animal Market, By Application
- Global Transgenic Animal Market, By Disease Area
- Global Transgenic Animal Market, By End User
- Global Transgenic Animal Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Transgenic Animal Market, By Animal Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Mice
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Zebrafish
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pigs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sheep
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Goats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chickens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Non-human primates rabbits)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Transgenic Animal Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Microinjection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Embryonic Stem Cell (ESC) Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nuclear Transfer (Cloning)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CRISPR/Cas9 and Other Gene Editing Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Viral Vector-mediated Transgenesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Transgenic Animal Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biomedical Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Toxicology and Safety Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Disease Modeling
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Xenotransplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biopharmaceutical Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Agricultural Trait Enhancement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Transgenic Animal Market, By Disease Area, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Immunological and Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Genetic and Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Transgenic Animal Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Agricultural Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Government and Regulatory Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Transgenic Animal Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Taconic Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
genOway
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cyagen Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biocytogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Transgenic Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ozgene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PolyGene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hera BioLabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ingenious Targeting Laboratory
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Applied StemCell
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GemPharmatech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Harbour BioMed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Crown Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pharmaron
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies